Potential role of BAY11-7082, a NF-κB blocker inhibiting experimental autoimmune encephalomyelitis in C57BL/6J mice via declining NLRP3 inflammasomes

Yue Lang(Shanghai University), Jie Zhu(Karolinska University Hospital)

Clinical & Experimental Immunology

November 27, 2021

10.1093/cei/uxab022

Cited by 25

Related Papers

Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab

|Frontiers in Aging Neuroscience|2022|257

1,25‐dihydroxyvitamin D<sub>3</sub>‐induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells

|Immunology|2017|96

Diversity of immune cell types in multiple sclerosis and its animal model: Pathological and therapeutic implications

|Journal of Neuroscience Research|2017|47

Neuroprotective effect of matrine on MPTP-induced Parkinson's disease and on Nrf2 expression

|Oncology Letters|2016|43

Peripheral blood amyloid-β involved in the pathogenesis of Alzheimer’s disease via impacting on peripheral innate immune cells

|Journal of Neuroinflammation|2024|43